VANCOUVER, BC, Nov. 22, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results for the quarter and year ended August 31, 2021 after market close on Thursday, December 9, 2021. Interested parties are invited to participate in…


Previous articlePsychedelic Bulletin: DEA Again Increases Psychedelics Production Quotas; MindMed Announces Microdosing Study; Shorter Trips?
Next articleCOMPASS Pathways granted fifth US patent for crystalline psilocybin